rewirebio.iobenchmarks
Evidence claim

Relevance of Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture protocol to "Select a DNA pathogen-identification workflow for diagnostic testing"

Use case
Select a DNA pathogen-identification workflow for diagnostic testing
Assessed by
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture protocol
Relevance
Proxy evidence
Endpoint
Positive percent agreement with initial blood culture for plasma microbial cfDNA sequencing in a prospective sepsis-alert cohort (59/63 initial-blood-culture-positive subset)

Positive percent agreement against initial blood culture is a proxy for sensitivity against all true infections, since initial blood culture does not identify every infection.

1 reviewed evaluation

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

15 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Citation locations
1 values
  • source id
    amp-20261007-dna-pathogens-source
    locator
    See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
2 values
  • Inspect every linked evaluation's source locator and preserved conflicts before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results.
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
Positive percent agreement with initial blood culture for plasma microbial cfDNA sequencing in a prospective sepsis-alert cohort (59/63 initial-blood-culture-positive subset)
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Claimed field
links:assessed_by:amp-20261007-dna-pathogens-protocol
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Limitations
5 values
  • Positive agreement uses initial blood culture as reference, which does not identify all infections. It is not sensitivity against all true infections.
  • Exact executable/software/database revision is not established; no foundation model and no new execution.
  • Composite-reference outcomes and estimates are separate endpoints; Table 2 negative composite CI54.8–70.0 conflicts with narrative55.2–70.4 and is excluded.
  • DNA-only plasma microbial cfDNA assay; no RNA viral detection or RNA sensitivity implied.
  • Primary article hosted on third-party rious168 mirror; DOI/title match publisher. Public redistribution licence absent; only compact factual table excerpt retained, original PDF retrieval hash preserved.
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.limitations

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Pinned records
5 values
  • record id
    amp-20261007-dna-pathogens-evaluation
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    ce8617fbc13f8282b5e955f0d7cef8eb3251a97486ebaea814c4af52e32361eb
  • record id
    amp-20261007-dna-pathogens-protocol
    fields
    • status
    • name
    • description
    • facets
    • source_ids
    • links
    • attributes
    sha256
    9adcc42991495a454d89c8419779e9011fb7adf847dd162fde7fd4c8bb515f42
  • record id
    amp-20261007-dna-pathogens-result
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    ecf440edaaa50989e51c19ebf3a60de36b70dc82038b5a19064e6898c9ad6b20
  • record id
    amp-20261007-dna-pathogens-source
    fields
    • status
    • attributes.artifact_sha256
    sha256
    a104308fb7c3a4f95e415764d658fabf6744207f0197bcc9ad06959a9039fb65
  • record id
    use-case-diagnostic-dna-pathogen-identification
    fields
    • status
    • name
    • description
    • facets
    • attributes.question
    • attributes.decision
    • attributes.inputs
    • attributes.output
    • attributes.exclusions
    • attributes.setting
    • attributes.clinical_scope
    • attributes.intended_users
    sha256
    fc133441f475bb23dafd0c0c55f4e16cd20302f9148b21b98de31077dfe16338
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.pins

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Rationale
Positive percent agreement against initial blood culture is a proxy for sensitivity against all true infections, since initial blood culture does not identify every infection.
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.rationale

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Reason
Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365).
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.reason

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Relevance
proxy
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.relevance

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Revision
1
Context-only references
Karius 2019 plasma microbial cfDNA positive agreement with initial blood culture source

Original source ↗

amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/

Version: Blauwkamp et al., Nature Microbiology 4, 663–674 (2019)
Retrieved: 2026-10-07T12:27:21.172039+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.revision

Source artifact SHA-256: 3256a8fc4624958df4b1c7bb84632c7021240cf9471e558b625c149827a024ba

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-amp-20261007-issue13

field
links:assessed_by:amp-20261007-dna-pathogens-protocol
value
amp-20261007-dna-pathogens-protocol
relevance
proxy
endpoint
Positive percent agreement with initial blood culture for plasma microbial cfDNA sequencing in a prospective sepsis-alert cohort (59/63 initial-blood-culture-positive subset)
rationale
Positive percent agreement against initial blood culture is a proxy for sensitivity against all true infections, since initial blood culture does not identify every infection.
constraints
Inspect every linked evaluation's source locator and preserved conflicts before citing a result.; Do not combine this mapping's evaluations with any other protocol's results.
limitations
Positive agreement uses initial blood culture as reference, which does not identify all infections. It is not sensitivity against all true infections.; Exact executable/software/database revision is not established; no foundation model and no new execution.; Composite-reference outcomes and estimates are separate endpoints; Table 2 negative composite CI54.8–70.0 conflicts with narrative55.2–70.4 and is excluded.; DNA-only plasma microbial cfDNA assay; no RNA viral detection or RNA sensitivity implied.; Primary article hosted on third-party rious168 mirror; DOI/title match publisher. Public redistribution licence absent; only compact factual table excerpt retained, original PDF retrieval hash preserved.
revision
1
reason
Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365).
citation locators
source id: amp-20261007-dna-pathogens-source; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
source locator
amp-20261007-dna-pathogens-source: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
review
method: automated-source-review; reviewer: codex; claude-sonnet; reviewer note: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values; independently reviewed by Codex (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); reviewed at: 2026-10-07T13:38:59Z; note: Bounded primary-source transcription, independently Codex-checked. No new model execution, independent experimental reproduction, qualified human scientific review or clinical validation.
reviewed evaluations
amp-20261007-dna-pathogens-evaluation
pins
record id: amp-20261007-dna-pathogens-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: ce8617fbc13f8282b5e955f0d7cef8eb3251a97486ebaea814c4af52e32361eb; record id: amp-20261007-dna-pathogens-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: 9adcc42991495a454d89c8419779e9011fb7adf847dd162fde7fd4c8bb515f42; record id: amp-20261007-dna-pathogens-result; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: ecf440edaaa50989e51c19ebf3a60de36b70dc82038b5a19064e6898c9ad6b20; record id: amp-20261007-dna-pathogens-source; fields: status; attributes.artifact_sha256; sha256: a104308fb7c3a4f95e415764d658fabf6744207f0197bcc9ad06959a9039fb65; record id: use-case-diagnostic-dna-pathogen-identification; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: fc133441f475bb23dafd0c0c55f4e16cd20302f9148b21b98de31077dfe16338
Related records

Suggest a correction